NEUPATH HEALTH INC.

Insiders NeuPath Health Inc.

Equities

NPTH

CA64133P1009

Market Closed - Toronto S.E. Other stock markets 20:59:58 28/05/2024 BST			5-day change	1st Jan Change
0.195 ^CAD	0.00%		+14.71%	+5.41%

03-15	NeuPath Health Narrows Q4 Loss, Revenue Rises	MT
03-15	NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

NeuPath Health Inc Announces Board Changes	19/10/22	CI
NeuPath Health Executive Chair Dianne Carmichael Steps Down, Names Interim CEO; Suspends Software Development	30/09/22	MT
NeuPath Health Inc. Announces Resignation of Dianne Carmichael as Director and Executive Chair	30/09/22	CI
NeuPath Health Inc. Appoints Joseph Walewicz as Interim Chief Executive Officer	30/09/22	CI
Neupath Health Inc. Announces Management Changes	25/07/22	CI
NeuPath Health Inc. Announces Grant Connelly Step Down from Chief Executive Officer, on or Before August 19, 2022	25/07/22	CI
NeuPath Health Reports Widened Q4 Loss, Revenue Rises; Appoints CFO	18/03/22	MT
Neupath Health Inc. Appoints Jeff Zygouras as Corporate Secretary	16/03/22	CI
NeuPath Health Inc. Appoints Jeff Zygouras as Chief Financial Officer	16/03/22	CI
Titan Medical : Dual-Listed Titan Medical Names NeuPath Health's Former CFO to Same Post	12/07/21	MT
NeuPath Health Inc. Appoints Ben Fagan as Chief Technology Officer	09/06/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer